行情

AVGR

AVGR

Avinger
NASDAQ

实时行情|Nasdaq Last Sale

0.8194
-0.0156
-1.87%
交易中 11:28 09/24 EDT
开盘
0.8300
昨收
0.8350
最高
0.8300
最低
0.8130
成交量
35.30万
成交额
--
52周最高
2.670
52周最低
0.2139
市值
7,813.22万
市盈率(TTM)
-3.3027
分时
5日
1月
3月
1年
5年
Avinger 收益观点:已用资本回报率
According to data from Benzinga Pro, during Q2, Avinger's (NASDAQ:AVGR) reported sales totaled $2.80 million. Despite a 5.21% increase in earnings, the company posted a loss of $4.41 million.
Benzinga · 1天前
Avinger 将于 9 月 13 日至 15 日出席 HC Wainwright 第 23 届年度全球投资会议
REDWOOD CITY, CA / ACCESSWIRE / September 8, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disea...
ACCESSWIRE · 09/08 12:45
Avinger(纳斯达克股票代码:AVGR)是否拥有健康的资产负债表?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Simply Wall St. · 09/03 11:38
Avinger OCT 引导技术在 AMP 2021 上亮相
REDWOOD CITY, CA / ACCESSWIRE / August 16, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease...
ACCESSWIRE · 08/16 12:01
12 只医疗保健股在周二的盘后交易时段内移动
Gainers
Benzinga · 08/10 20:52
Avinger:第二季度收益洞察
Shares of Avinger (NASDAQ:AVGR) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 77.78% year over year to ($0.04), which were in line with the estimate of ($0.04).
Benzinga · 08/10 20:35
Avinger Q2 EPS $(0.04), Inline, 销售额 280 万美元超过 272 万美元的估计
Avinger (NASDAQ:AVGR) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 77.78 percent increase over losses of $(0.18) per share from the same period last year. The
Benzinga · 08/10 20:24
Avinger 报告 2021 年第二季度财务业绩
Pantheris Sales and Tigereye™ Expansion Drive 91% Year-Over-Year Revenue GrowthREDWOOD CITY, CA / ACCESSWIRE / August 10, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided,...
ACCESSWIRE · 08/10 20:01
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解AVGR最新的财务预测,通过AVGR每股收益,每股净资产,每股现金流等数据分析Avinger近期的经营情况,然后做出明智的投资选择。
分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测AVGR价格均价为2.500,最高价位2.500,最低价为2.500。
EPS
机构持股
总机构数: 45
机构持股: 1,109.63万
持股比例: 11.64%
总股本: 9,535.30万
类型机构数股数
增持
4
146.05万
建仓
6
85.13万
减持
7
20.54万
平仓
8
65.44万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
先进医疗设备和技术
-0.51%
医疗设备和用品
-0.57%
高管信息
Non-Executive Chairman/Independent Director
James Cullen
President/Chief Executive Officer/Director
Jeffrey Soinski
Chief Financial Officer
Mark Weinswig
Chief Technology Officer
Himanshu Patel
Independent Director
Tamara Elias
Independent Director
James McElwee
暂无数据
AVGR 简况
Avinger Inc是一家商业阶段的医疗设备公司。该公司设计、制造和销售影像导航导管系统,供医生用于治疗外周动脉疾病(PAD)患者。该公司通过Lumivascular技术平台进行运营。lumivvascular平台集成了光学相干断层成像(OCT)可视化和介入导管,在PAD治疗过程中提供实时血管内成像。还包括一个资本组件、Lightbox和各种一次性导管产品,包括Ocelot和Pantheris系列导管。该公司的Lightbox是一种视频成像控制台,可在PAD手术期间使用lumivvascular导管。该公司的Pantheris是一种一次性产品,为医生提供了外周动脉横断面视图的能力,以指导在整个手术过程中清除堵塞物。

微牛提供Avinger Inc(NASDAQ-AVGR)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的AVGR股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易AVGR股票基本功能。